| Structure | Chemical Name | CAS | MF |
|
4H,8H-Benzo[1,2-c:4,5-c']dithiophene-4,8-dione, 1,3-bis(5-bromo-2-thienyl)-5,7-bis(2-butyloctyl)-
|
2093197-75-0
|
C42H54Br2O2S4
|
|
2-((2-butyloctyl)thio)thiophene
|
2093197-82-9
|
C16H28S2
|
|
1,3-Dibromo-5,7-bis-(2-hexyldecyl)-2,6-dithia-s-indacene-4,8-dione
|
2093197-87-4
|
C42H66Br2O2S2
|
|
1,3-Bis(5-bromothiophen-2-yl)-5,7-bis(2-butyloctyl)benzo[1,2-c:4,5-c']dithiophene-4,8-dione
|
2093197-88-5
|
C34H50Br2O2S2
|
|
BDP FL-PEG5-azide
|
2093197-91-0
|
C26H39BF2N6O6
|
|
BDP FL-PEG5-propargyl
|
2093197-93-2
|
C27H38BF2N3O6
|
|
BDP FL DBCO
|
2093197-94-3
|
C32H29BF2N4O2
|
|
BDP FL-PEG5-acid
|
2093197-98-7
|
|
|
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
|
2093243-16-2
|
C17H13NO4
|
|
2-((1r,4r)-4-(tert-butoxycarbonyl)cyclohexyl)ethyl 4-methylbenzenesulfonate
|
2093293-77-5
|
C20H31NO5S
|
|
L-Isoleucinamide, O-(phosphono-κO)-N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-
|
2093305-05-4
|
C27H45N4O8P
|
|
2-bromo-6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridine
|
2093329-79-2
|
C10H11BrN4
|
|
6,6'-bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-2,2'-bipyridine
|
2093382-71-7
|
C24H30N4O2
|
|
PROTAC 11
|
2093386-22-0
|
C44H45N11O9
|
|
Glycine, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-, 1,1-dimethylethyl ester
|
2093386-23-1
|
C19H21N3O6
|
|
2,6-Piperidinedione, 3-(4-bromo-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-1-methyl-
|
2093386-30-0
|
C14H13BrN2O3
|
|
4-[(5-Aminopentyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
2093386-39-9
|
C18H22N4O4
|
|
4-((5-Aminopentyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 2,2,2-trifluoroacetate
|
2093386-40-2
|
C20H23F3N4O6
|
|
4-[(6-Aminohexyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
2093386-50-4
|
C19H24N4O4
|
|
Thalidomide-NH-C6-NH2 TFA
|
2093386-51-5
|
C21H25F3N4O6
|
|
3-(4-bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione
|
2093387-36-9
|
C13H11BrN2O3
|
|
Thalidomide-NH-C4-NH2 TFA
|
2093387-50-7
|
C19H21F3N4O6
|
|
4-[(7-Aminoheptyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
2093387-55-2
|
C20H26N4O4
|
|
9H-Pyrimido[4,5-b]indole-2-carboxylic acid, 4-[(3-cyclopropyl-1-ethyl-1H-pyrazol-5-yl)amino]-7-(3,5-dimethyl-4-isoxazolyl)-6-methoxy-
|
2093387-77-8
|
C25H25N7O4
|
|
4-((3-aminopropyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2093388-20-4
|
C16H18N4O4
|
|
Pomalidomide Related Compound 9 Triflate
|
2093388-21-5
|
C18H19F3N4O6
|
|
PROTAC BET degrader-2
|
2093388-33-9
|
C41H42N10O6
|
|
E3 Ligand-Linker Conjugate 4
|
2093388-45-3
|
C18H23N3O3
|
|
Thalidomide-NH-C4-NH-Boc
|
2093388-52-2
|
C22H28N4O6
|
|
BETd-260
|
2093388-62-4
|
C43H46N10O6
|
|
E3 Ligand-Linker Conjugate 5
|
2093388-69-1
|
C17H21N3O3
|
|
HJB-97
|
2093391-24-1
|
C26H28N8O3
|
|
TC13172
|
2093393-05-4
|
C17H16N4O5S
|
|
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-((5-(4-fluorophenyl)-1H-indazol-3-yl)amino)-4-methoxyphenyl)acrylamide
|
2093395-24-3
|
C28H31FN6O2
|
|
OTS186935
|
2093400-18-9
|
C25H26ClN5O2
|
|
KY-02327
(KY02327)
|
2093407-25-9
|
C20H27N3O4
|
|
DBCO-PEG3-amine
|
2093409-57-3
|
C27H33N3O5
|
|
1,1'-Bis[3-(trimethylammonio)propyl]ferrocene Dichloride
|
2093414-16-3
|
C22H30ClFeN2+
|
|
4-((2-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2093416-31-8
|
C21H28N4O7
|
|
4-((2-(2-(2-aminoethoxy)ethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2093416-32-9
|
C19H24N4O6
|
|
QM385
|
2093421-02-2
|
C17H18F3N7O2
|
|
tert-butyl 3-(2-fluoropyridin-4-yl)azetidine-1-carboxylate(WX160396)
|
2093427-33-7
|
C13H17FN2O2
|
|
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
2093536-12-8
|
C13H9BrN2O4
|
|
Carbamic acid, N-[6-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]hexyl]-, 1,1-dimethylethyl ester
|
2093536-13-9
|
C24H32N4O6
|
|
2-((4,4-dimethylcyclohexyl)sulfonyl)-7-((4-(1-phenylethyl)piperazin-1-yl)sulfonyl)-9H-fluoren-9-one oxime
|
2093565-23-0
|
C33H39N3O5S2
|
|
Azadibenzocyclooctyne-PEG12-N-hydroxysuccinimidyl ester
|
2093934-94-0
|
(C2H4O)nC28H27N3O7
|
|
3-cyclobutyl-1-(4-fluorophenyl)-1H-pyrazol-5-amine(WXFC0756)
|
2093978-05-1
|
C13H14FN3
|
|
4-(methoxymethyl)piperidin-4-ol hydrochloride
|
2093979-92-9
|
C7H16ClNO2
|
|
D-Serine, O-ethyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
|
2093993-48-5
|
C20H21NO5
|
|
1,3-Pyrrolidinedicarboxylic acid, 2-phenyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2R,3S)-
|
2094028-78-9
|
C26H23NO4
|
|
trans-3-methoxycyclobutanemethanamine hydrochloride
|
2094029-36-2
|
C6H14ClNO
|
|
2-(2-ethyl-4,6-dimethylpyrimidin-5-yl)acetic acid hydrochloride
|
2094145-48-7
|
C10H15ClN2O2
|
|
1-cyclopropylcyclobutan-1-amine hydrochloride
|
2094149-86-5
|
C7H14ClN
|
|
tert-butyl N-[3-(aminomethyl)cyclobutyl]carbamate hydrochloride
|
2094411-58-0
|
C10H21ClN2O2
|
|
3,5-Difluoro-4-methylphenylboronic acid pinacol ester
|
2094504-03-5
|
C13H17BF2O2
|
|
EN40
|
2094547-67-6
|
C13H15NO2
|
|
Brexpiprazole Impurity 2
|
2094559-58-5
|
C38H40N4O4S
|
|
(2R,3R,4R,5S)-1,6-bis(dodecylamino)hexane-2,3,4,5-tetraol
|
2094574-05-5
|
C30H64N2O4
|
|
(2R,3R,4R,5S)-1,6-bis(hexadecylamino)hexane-2,3,4,5-tetraol
|
2094574-06-6
|
C38H80N2O4
|
|
Boronic acid, B-(2-phenyl-7-benzoxazolyl)-
|
2094605-85-1
|
C13H10BNO3
|
|
7-bromo-8-fluoroisoquinoline
|
2094685-40-0
|
C9H5BrFN
|
|
4-(pyridin-4-yl)azepane dihydrochloride
|
2094713-86-5
|
C11H17ClN2
|
|
4-amino-1-[2-(2-fluorophenyl)-2-oxoethyl]-4H-1,2,4-Triazolium, bromide (1:1) (ACI)
|
2094735-34-7
|
C10H10BrFN4O
|
|
3H-3a,6-Methano-2,1-benzisothiazole, hexahydro-8,8-dimethyl-1-[(trifluoromethyl)thio]-, 2,2-dioxide, (3aS,6R,7aR)-
|
2094737-51-4
|
C11H16F3NO2S2
|
|
2-(methylamino)ethane-1-sulfonamide hydrochloride
|
2094744-53-1
|
C3H11ClN2O2S
|
|
2-(piperidin-3-yl)pyrimidine dihydrochloride
|
2094861-76-2
|
C9H14ClN3
|
|
2-Piperazinone, 1-(5-methyl-2-furanyl)-4-(1-oxo-2-propen-1-yl)-
|
2094893-05-5
|
C12H14N2O3
|
|
Apremilast impurity 19
|
2095036-40-9
|
C20H20N2O8S
|
|
(R)-5-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl) phenyl)-2-(2-methyl-2H-tetrazol-5-yl)pyridine 1-oxide
|
2095100-93-7
|
C17H15FN6O4
|
|
CAY10723
|
2095107-57-4
|
C24H27FN6O3
|
|
Berkeleylactone F
|
2095114-72-8
|
C16H28O5
|
|
BI 907828
|
2095116-40-6
|
C31H25Cl2FN4O3
|
|
(3aR,8aS)-2-(Quinolin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
|
2095128-11-1
|
C19H14N2O
|
|
MA-0204
|
2095128-17-7
|
C25H27F3N2O4
|
|
Hexanoic acid, 3-methyl-6-[2-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-1-yl]methyl]phenoxy]-, (3R)-
|
2095128-20-2
|
C25H27F3N2O3
|
|
HSL-IN-1
|
2095156-13-9
|
C19H13BClF3N2O4
|
|
5-(5-(ethoxycarbonyl)-4-methylthiazol-2-yl)-2-isobutoxybenzoic acid
|
2095166-41-7
|
C18H21NO5S
|
|
Dapoxetine impurity 11/(S)-N-Didemethyl Dapoxetine HCl/(S)-α-[2-(1-Naphthalenyloxy)ethyl]benzenemethanamine Hydrochloride
|
2095189-99-2
|
C19H20ClNO
|
|
tert-butyl 6-azaspiro[2.5]oct-1-ylcarbamate hydrochloride
|
2095192-33-7
|
C12H23ClN2O2
|
|
(R)-5-(2-fluoro-4-(2-oxo-5-((phosphonooxy)methyl)oxazolidin- 3-yl)phenyl)-2-(2-methyl-2H-tetrazol-5-yl)pyridine 1-oxide
|
2095200-68-1
|
C17H16FN6O7P
|
|
Tedizolid Impurity 34
|
2095200-69-2
|
C16H18FN6O5P
|
|
Fmoc-Ile-(Dmb)Gly-OH
|
2095208-17-4
|
C32H36N2O7
|
|
5'-amino-[1,1':3',1"-te rphenyl]-3,3",5,5"-tet racarboxylic acid
|
2095221-49-9
|
C22H15NO8
|
|
Benzaldehyde, 3-chloro-4-hydroxy-2-methyl-
|
2095236-70-5
|
C8H7ClO2
|
|
8-Bromo-5-chloro-imidazo[1,2-c]pyrimidine
|
2095237-01-5
|
C6H3BrClN3
|
|
M-2
|
2095240-92-7
|
C34H23ClN2
|
|
E3 ligase Ligand 12
|
2095244-42-9
|
C31H42N4O6S
|
|
SNIPER(BRD)-1
|
2095244-54-3
|
C53H66ClN9O8S2
|
|
PROTAC IAP binding moiety 2
|
2095244-62-3
|
C33H45N5O4
|
|
tert-butyl trans-3-hydroxy-2-methylazetidine-1-carboxylate
|
2095250-24-9
|
C9H17NO3
|
|
(S)-5-Benzyl-2-(perfluorophenyl)-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate
|
2095252-36-9
|
C18H13BF9N3
|
|
2-(3-TERT-BUTYL-5-CHLOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
|
2095254-96-7
|
C16H24BClO2
|
|
Ketoconazole Impurity 17
|
2095256-87-2
|
C21H20Cl2N2O5S
|
|
[1,?1':3',?1''-?Terphenyl]?-?2,?2'',?4,?4'',?5'-?pentacarboxylic acid
|
2095288-22-3
|
C23H14O10
|
|
1,3,5-Tris(5-chloropyridin-3-yl)benzene
|
2095298-29-4
|
C21H12Cl3N3
|
|
(S)-2-([2,2'-bipyridin]-6-yl)-4-(tert-butyl)-4,5-dihydrooxazole
|
2095304-34-8
|
C17H19N3O
|
|
Bosutinib Impurity 5
|
2095306-22-0
|
C17H18N2O8
|
|
Bosutinib Impurity 38
|
2095306-26-4
|
C46H44Cl4N8O6
|
|
Bosutinib Impurity 37
|
2095306-27-5
|
C39H30Cl4N6O6
|
|
Ethanone, 1-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-
|
2095308-80-6
|
C17H26O3
|